There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …

Urinary retention is common after anesthesia and surgery, reported incidence of between 5%
and 70%. Comorbidities, type of surgery, and type of anesthesia influence the …

PTEN haploinsufficiency is common in hormone‐sensitive prostate cancer, though the
incidence of genomic deletion and its downstream effects have not been elucidated in clinical …

BACKGROUND Wnt‐1 and β‐catenin expression levels play an important role in several
malignancies. The authors determined the level of production of Wnt‐1 and β‐catenin in …

Introduction Although urinary cytology (C) is the most widely used noninvasive test for the
detection and surveillance of bladder cancer (BC), it has poor sensitivity especially for low-…

BACKGROUND Late‐stage prostate cancer patients are refractory to hormone therapy and
exhibit a high propensity to develop skeletal metastasis. In this regard, the role of a novel …

Pp125 FAK , a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion
plaques, is known to transduce signals involved in the regulation of cell adhesion and motility …

OBJECTIVES: To evaluate, in a multicenter study, the diagnostic performance of a new
molecular test uPM3 for detecting prostate cancer cells in urine because of the need for better …

… Oriana Yu, Maria Eberg, Serge Benayoun, Armen Aprikian, Gerald Batist, Samy Suissa,
and Laurent Azoulay … Jewish General Hospital; Oriana Yu, Armen Aprikian, Gerald Batist …

Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVE To evaluate data obtained
from a large, multi‐institutional, contemporary series of patients who underwent radical …